Navigation Links
Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
Date:1/5/2009

SAN CARLOS, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 27th Annual J.P. Morgan Healthcare Conference in San Francisco at the Westin St. Francis Hotel on Tuesday, January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until February 15, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its advanced polymer conjugate technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com.

     Nektar Contacts:
     Jennifer Ruddock
     Nektar Therapeutics
     650-631-4954
     jruddock@nektar.com

     Susan Noonan
     The SAN Group
     212-966-3650
     susan@sanoonan.com

'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
2. Nektar Therapeutics to Webcast R&D Day on November 12th
3. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
4. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
6. Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets
7. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
8. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
9. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
10. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
11. West Concludes Agreement with Nektar

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , TORONTO, Nov. 24 /PRNewswire-FirstCall/ - ...o Capital Inc., a leading provider of advanced las...rch and fertility clinic markets, today reported o...rter ended September 30, 2009. , , Q3 2009 Hig...d with $1.43 million in Q3 2008, - Gross prof...
(Date:11/24/2009)...v. 24, 2009 Arena Pharma... that the company is scheduled to present at the P... December 1, 2009 at 11:30 a.m. Eastern Time (8:30...n New York City. Jack Lief, Arena,s President and ...n overview of the company, including its clinical ...
(Date:11/24/2009)...ly, November 24 Health Robotics to...int venture with a group of selected,investors. Th...ate under the,name Health Robotics Canada, Inc. an...s, i.v. Room of the Future concept, which includes...M), i.v.SOFT(TM), and OMM(TM).,Health Robotics Can...
(Date:11/24/2009)...mical Abstracts Service (CAS), the global expert o...t office is now the world,s leading producer of pa...ailed Japan,s patent office, the World Intellectua...tes Patent and Trademark Office (USPTO) for more t...n 2006, and exceeded Japan for the first time on a...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...ov. 25 Pharos Innovations, a pioneer in,assisting...inancial,performance improvement through a device-...artnership to Fight Chronic Disease (PFCD), a coal...licy and labor communities committed,to making chr...residential,administration. , (Logo: http:...
...ov. 25 TorreyPines Therapeutics, Inc.,(Nasdaq: ...Eli Lilly & Company,a reduction in certain roy...on,net sales of TorreyPines, clinical-stage compou...in regulatory approval. Specifically, the top tier...nts and the middle tier,royalty rate will be reduc...
... Nov. 25 Tengion Inc., a clinical stage regenerat... neo-organs and neo-tissues, today announced that ...utive Officer of Tengion, will present at the Pipe...sday, December 2, 2008 at 9:50 a.m. EST at The Pal...out Tengion , , Tengion, a clinical stage re...
Other Biology Technology:Pharos Innovations Joins Partnership to Fight Chronic Disease 2Pharos Innovations Joins Partnership to Fight Chronic Disease 3TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel 2
(Date:11/24/2009)...ass of ring-shaped protein motors has been uncover...nal Laboratory (Berkeley Lab) using a state-of-the...ced Light Source (ALS). These protein motors play ...and are vital to the survival of all biological ce...an papillomavirus, which has been linked to cervic...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)... day matters to forest trees dealing with drought,...eam led by Professor Malcolm Campbell, University ...ch and colleagues in the department of cell and sy...talizing on their previous work to decode the geno...how poplar trees use their 45,000 genes to respond...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Healing power of aloe vera proves beneficial for teeth and gums too 9276 1Healing power of aloe vera proves beneficial for teeth and gums too 9276 2EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 1EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 2EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 3EngagementHealth 28R 29 Launches Comprehensive Wellness Program with Store Kraft 80 25 of Employees and Spouses Participate in Programs 52042 4BioMS Medical announces second quarter 2009 results 13079 1BioMS Medical announces second quarter 2009 results 13079 2BioMS Medical announces second quarter 2009 results 13079 3BioMS Medical announces second quarter 2009 results 13079 4BioMS Medical announces second quarter 2009 results 13079 5BioMS Medical announces second quarter 2009 results 13079 6BioMS Medical announces second quarter 2009 results 13079 7BioMS Medical announces second quarter 2009 results 13079 8BioMS Medical announces second quarter 2009 results 13079 9
...Alzheimer,s disease, physician-scientists at NewYo...ter have identified naturally occurring antibodies...is form of dementia as well as other neurodegenera...tively target aggregates of beta amyloid proteins ...while ignoring the benign single-molecule forms of...
...Conservation Society confirm the existence of more...and Mongalla gazelle in Southern Sudan, where wild...ecades-long conflict. Despite the war, some specie...e than 25 years ago, have not only survived but ha...rival those of the Serengeti. , The survey project...
...n Prize in biodiversity informatics, works at the ...Prize has been awarded to Paul Flemons of the Aust...ormation Facility (GBIF) established the Prize in ...irational leader in the fields of biosystematics a...e in the world that is given in the area of biodiv...
Other Biology News:Newly discovered antibody may be body's natural defense against Alzheimer's 2Newly discovered antibody may be body's natural defense against Alzheimer's 3Massive herds of animals found to still exist in Southern Sudan 2Massive herds of animals found to still exist in Southern Sudan 3Massive herds of animals found to still exist in Southern Sudan 4Massive herds of animals found to still exist in Southern Sudan 5Massive herds of animals found to still exist in Southern Sudan 6Australian wins prestigious prize in biodiversity informatics 2
Mouse Anti-Human ADAM10 Ectodomain Monoclonal Antibody, Unconjugated, Clone 163003 from R&D Systems
Rabbit Anti-Human HCARG Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Human SOST Polyclonal Antibody, Unconjugated from R&D Systems
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Biology Products: